NF-κB signaling mediates acquired resistance after PARP inhibition.
Nakagawa Y, Sedukhina AS, Okamoto N, Nagasawa S, Suzuki N, Ohta T, Hattori H, Roche-Molina M, Narváez AJ, Jeyasekharan AD, Bernal JA, Sato K.
Nakagawa Y, et al. Among authors: ohta t.
Oncotarget. 2015 Feb 28;6(6):3825-39. doi: 10.18632/oncotarget.2868.
Oncotarget. 2015.
PMID: 25686825
Free PMC article.